Codexis Announces CodeEvolver Technology Transfer and License Agreement With Merck
Under the terms of the agreement,
"This licensing transaction builds upon our productive eight-year relationship with Merck and further validates the ability of CodeEvolver to effectively and cost-efficiently improve certain manufacturing processes," stated
"This technology transfer and licensing agreement builds upon our long standing collaboration in biocatalysis with
A recording of the call will be available for 48 hours beginning approximately two hours after the completion of the call by dialing 855-859-2056 for domestic callers or 404-537-3406 for international callers. Please use the passcode 3076907 to access the replay. A webcast replay will be available on the Investors section of www.codexis.com for 30 days, beginning approximately two hours after the completion of the call.
About CodeEvolver® Protein Engineering Platform Technology
This press release contains forward-looking statements relating to